Top Markets
Coin of the day
NuVasive, Inc. NuVasive, Inc.

NuVasive, Inc.

NUVA
株式のランク #6445
NuVasive, Inc. is a medical technology firm focused on creating, producing, and... NuVasive, Inc. is a medical technology firm focused on creating, producing, and distributing comprehensive procedural solutions for spinal operations. The company offers a range of surgical access instruments, such as the Maxcess integrated split-blade retractor system, which facilitates less-invasive surgical approaches by significantly reducing soft tissue disruption during spinal procedures. Additionally, NuVasive manufactures specialized spinal implants designed to improve spinal fusion by optimizing the osseointegration and biomechanical characteristics of materials like porous titanium and porous polyetheretherketone. Its fixation systems are engineered to help maintain and re-establish proper patient alignment. Other offerings include cervical total disc replacement technology, used in cervical spinal fusion surgery, and advanced neuromonitoring systems. These systems leverage proprietary software for nerve detection and avoidance, complemented by comprehensive intraoperative neuromonitoring services and support. The Pulse platform, a distinctive software ecosystem, unifies various hardware technologies into a compact, integrated system within the operating room environment. Furthermore, NuVasive supplies expandable growing rod implant systems for managing early-onset scoliosis, along with diverse biologics crucial for supporting spinal fusion or bone healing. Another key product is Precice, an intramedullary implant device that employs MAGEC technology for the non-invasive lengthening of the femur and tibia. The company also offers both onsite and remote monitoring solutions for the neurological systems of patients undergoing spinal and brain-related surgical interventions. NuVasive distributes its products to a broad client base, including patients, surgeons, hospitals, and insurers, through a multi-channel sales approach encompassing independent sales agents, its own sales force, and distributors, operating across the United States and global markets. Established in 1997, NuVasive, Inc. maintains its corporate headquarters in San Diego, California.
株価
$39.75
最終同期: 2023-09-08
時価総額
$2.04B
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 NuVasive, Inc. (NUVA)

カテゴリー

NuVasive, Inc.(NUVA)の営業利益率
2026 時点の営業利益率 TTM: 0.00%
NuVasive, Inc. の最新の財務報告と株価によると、現在の営業利益率(TTM)は 0.00% です。2026 年末時点では 0.00% でした。
NuVasive, Inc. の営業利益率の履歴(2026 から 2026)
各年末の営業利益率
営業利益率 変化
提供された日付のデータは十分ではありません。
同業他社の営業利益率
企業 営業利益率 営業利益率の差
17.03% -
US
22.03% -
US
17.86% -
IE
21.46% -
US
0.00% -
DE
企業の営業利益率とは?
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。